Skip to main content
. 2023 Apr 24;13(5):1077. doi: 10.3390/life13051077

Table 4.

Total subject number and RLN variations prevalence of the included studies.

Author N Patients Prevalence Number and Percentage
[3] 253 16/6.32%
[8] 2068 601/29.06%
[12] 1700 4/0.24%
[15] 603 4/0.66%
[27] 2658 15/0.56%
[64] 16 16/100%
[28] 4 4/100%
[11] 2158 16/0.74%
[30] 6 6/100%
[31] 137 101/73.72%
[32] 766 4/0.52%
[33] 49 16/32.65%
[36] 100 100/100%
[37] 993 3/0.30%
[38] 2068 858/41.49%
[40] 7392 28/0.38%
[41] 5344 128/2.39%
[42] 55 55/100%
[43] 294 294/100%
[45] 36 36/100%
[66] 2 2/100%
[68] 2404 690/28.7%
[58] 94 40/42.55%